Image shown may not represent actual product or configuration
The Abre™ venous self-expanding stent system is designed for the unique challenges of venous disease.
The Abre™ venous self-expanding stent system is intended for use in the iliofemoral veins for the treatment of symptomatic venous outflow obstruction.
The potential adverse events (or complications) that may occur or require intervention with the use of this device include, but are not limited to, the following:
Nonclinical testing demonstrated that the Abre™ stent in single and overlapped conditions is MR Conditional for stents up to 150 mm.
A patient with this device can be scanned safely, immediately after stent placement, under the following conditions:
MR image quality may be compromised if the area of interest is in the exact location or close to the position of the Abre™ stent.
Under the scan conditions as defined in the previous section, MR conditional, the Abre™ stent is expected to produce a maximum temperature rise less than or equal to 5.2 C after 15 minutes of continuous scanning (per pulse sequence). The effect of temperature rise in the MRI environment for stents with fractured struts is not known.
It is recommended that patients register conditions under which the implant can be scanned safely with the MedicAlert Foundation (medicalert.org) or equivalent organization.
In nonclinical testing, the maximum artifact size as seen on the gradient echo pulse sequence at 3.0 Tesla extends approximately 5 mm, relative to the size and shape of the Abre™ stent. The lumen of the stent can be visualized using the T1-weighted spin echo pulse sequence and the T1-weighted gradient echo pulse sequence at 3.0 Tesla.
UC202103705dEN
Find more information, including other available configurations, for Abre™ venous self-expanding stent system.